COVID-19 Genomics UK Consortium
The current COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents a major threat to health. The COVID-19 Genomics UK (COG-UK) consortium has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government.
COG-UK is made up of an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and over twelve academic partners providing sequencing and analysis capacity.
COG-UK is supported by £20 million funding from the UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, administered by UK Research and Innovation.
Viruses sequenced
80,689
Fantastic work from our @CovidGenomicsUK team at the Quadram sequencing #COVID19 genomes 👏👏👏 https://twitter.com/andrewjpage/status/1319200708089024513
774 #SARS-CoV-2 samples have just gone on a single #Illumina NextSeq run, thanks to the enormous efforts of the team at @TheQuadram particularly @AlexJTrotter Steven Rudder & @tweakyaustin
21st Oct 20 @covidgenomicsuk update: 79,012 of 116,586 global SARS-CoV-2 genomes. Figs: Lineages over time and mutation distribution https://microreact.org/project/cogconsortium
Scientists on lookout for Covid mutations which cause treatments to lose potency https://www.theguardian.com/world/2020/oct/20/scientists-on-lookout-for-covid-mutations-which-cause-treatments-to-lose-potency?utm_source=dlvr.it&utm_medium=twitter
